Form D · Other Health Care
InterAct Therapeutics, Inc.
Dallas, TX · CIK 0002107143
Offering snapshot reported Jul 21, 2026 · SEC filing
- Reported sold
- $250K Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 20, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 21, 2026 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-591571
Source: Form D, filed Jul 21, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Isaac Chan | Director |
| Daniel Hargrove | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3060 Pegasus Park Drive Building 6
Dallas, TX, 75247
Dallas, TX, 75247